ECCO 2019 European Cancer Summit Day 1

The purpose of phase I clinical trials are to evaluate the safety, dosage and potential side effects of a new drug or treatment in humans for the first time. In this touchONCOLOGY interview, we speak with Dr Vivek Subbiah (University ...

Precision medicine aims to tailor medical treatments to individual patients based on their characteristics and genetic makeup. Phase I clinical trials are seeing changes in their objectives and designs in the era of precision medicine. In this touchONCOLOGY interview, we ...

This July, the PrEvCan campaign is dedicated to raising awareness about women's cancer risk in connection with breastfeeding and hormone replacement therapy (HRT).  Initiated by the European Oncology Nursing Society (EONS), and with ESMO as a key campaign partner, the ...

The relationship between breastfeeding and a reduction in cancer risk is the focus of the PrEvCan Campaign, this July.  Initiated by the European Oncology Nursing Society (EONS), and with ESMO as a key campaign partner, the PrEvCan – Cancer Prevention Across ...

The European Code Against Cancer (ECAC) recommends that if you drink alcohol of any type you should limit your intake and that not drinking alcohol is best for cancer prevention. This March, the PrEvCan campaign, spearheaded by EONS to promote ...

The European Society of Surgical Oncology (ESSO), along with other cancer-related European societies, supported the proposal for cross-multidisciplinary training in oncology at the EU level. It was a pleasure to talk with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, Regensburg, Germany) ...

The European Society of Surgical Oncology (ESSO) recently released an open letter urging the European Commission to recognise surgical oncology as a specialist discipline in the EU, entitled 'Time to act: Maximizing the benefits of surgical oncology for cancer patients ...

Rare diseases can present numerous challenges for those living with these conditions and the healthcare professionals caring for them. In this interview we discuss some of these with Lisa Sarfaty, VP of Communication and Engagement for NORD (The National Organization ...

Our society partner, NORD (The National Organization for Rare Disorder) has planned several initiatives to support this year’s Rare Disease Day on 28 February.  These activities are aimed at raising awareness about rare diseases and the challenges faced by people ...

As part of our ongoing support for the PrEvCan - Cancer Prevention Across Europe - campaign, we were delighted to speak with the President of the European Oncology Nursing Society (EONS), Johan de Munter. Initiated by EONS, and with ESMO ...

The impact of the Russian invasion on Ukraine and how this has impacted clinical trials and cancer care in Europe. The Special Network on the Impact of the War in Ukraine on Cancer was established by ECO Board and ASCO ...

Professor Mark Lawler (Queen's University Belfast) summarizes the European Cancer Pulse, an exciting new tool that brings together data from 34 European countries and helps determine cancer care disparities on cancer burden, research spending, prevention efforts, early detection, diagnosis and treatment ...